7 studies were found.

1.		Recruiting	Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer Conditions: recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
2.		Recruiting	Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
3.		Recruiting	Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer
4.		Recruiting	Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
5.		Recruiting	Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases Conditions: stage II breast cancer; stage I breast cancer
6.		Recruiting	Trastuzumab in Treating Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
7.		Recruiting	Triptorelin Compared With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer